Major General Pollock is a two-star general who retired in 2008 after 36 years of service in the U.S. Army. She held the position of acting Surgeon General of the U.S. Army. Major General Pollock was the first woman and the first non-physician to serve in this role in any of the military services of the United States. In this capacity, Major General Pollock was responsible for a worldwide 24/7 medical operation with a budget of $9.7 billion and a staffing complement of approximately 6,500 people.
“I am very excited to join Covalon’s Board of Directors. Covalon has proven that it has a number of unique infection control and advanced wound care technologies that are just beginning to gain traction in the global marketplace," Major General Pollock said. "At the same time, Covalon has a number of extremely exciting technologies in the lab waiting to be commercialized.”
"Covalon is very fortunate to have someone of Major General Pollock’s stature join our Board of Directors," said Brian Pedlar, Covalon's CEO. "Gale has a very impressive career within the military as well as having become a champion of several extremely important initiatives since leaving the United States Army. Her years of leadership working within military and non-military healthcare systems will be an invaluable benefit to Covalon.”
While in the United States Army, Major General Pollock served as the commander of the United States Army Medical Command. Major General Pollock was also the 22nd Chief of the Army Nurse Corps.
Major General Pollock serves on multiple advisory boards and is the president of Pollock Associates LLC. She is a Fellow in the American College of Healthcare Executives, the American Academy of Nursing and the National Board of Corporate Directors. In 2008, Major General Pollock established the Louis J. Fox Center for Vision Restoration and was an associate professor at the University of Pittsburgh Schools of Medicine and Nursing. In 2011, Major General Pollock became a Harvard University Fellow in their “Advanced Leadership Initiative” program.
Major General Pollock has master’s degrees in business, healthcare administration, and national security and strategy. She received an honorary doctorate degree from the University of Maryland.
General Pollock’s appointment to Covalon’s Board of Directors is subject to approval.
Covalon Technologies Ltd. researches, develops, and commercializes new healthcare technologies. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.